Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Reduced Physiological Complexity in Robust Elderly Adults with the APOE ε4 Allele

  • Daniel Cheng ,

    Contributed equally to this work with: Daniel Cheng, Shih-Jen Tsai

    Affiliation Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, California, United States of America

  • Shih-Jen Tsai ,

    Contributed equally to this work with: Daniel Cheng, Shih-Jen Tsai

    Affiliations Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, Divisions of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan

  • Chen-Jee Hong,

    Affiliations Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan, Divisions of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Institute of Brain Science, National Yang-Ming University, Taipei, Taiwan

  • Albert C. Yang

    ccyang@physionet.org

    Affiliations Divisions of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Department of Psychiatry, Chu-Tung Veterans Hospital, Hsin-Chu County, Taiwan, Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

Reduced Physiological Complexity in Robust Elderly Adults with the APOE ε4 Allele

  • Daniel Cheng, 
  • Shih-Jen Tsai, 
  • Chen-Jee Hong, 
  • Albert C. Yang
PLOS
x

Abstract

Background

It is unclear whether the loss of physiological complexity during the aging process is due to genetic variations. The APOE gene has been studied extensively in regard to its relationship with aging-associated medical illness. We hypothesize that diminished physiological complexity, as measured by heart rate variability, is influenced by polymorphisms in the APOE allele among elderly individuals.

Methodology/Principal Findings

A total of 102 robust, non-demented, elderly subjects with normal functions of daily activities participated in this study (97 males and 5 females, aged 79.2±4.4 years, range 72–92 years). Among these individuals, the following two APOE genotypes were represented: ε4 non-carriers (n = 87, 85.3%) and ε4 carriers (n = 15, 14.7%). Multi-scale entropy (MSE), an analysis used in quantifying complexity for nonlinear time series, was employed to analyze heart-rate dynamics. Reduced physiological complexity, as measured by MSE, was significantly associated with the presence of the APOE ε4 allele in healthy elderly subjects, as compared to APOE ε4 allele non-carriers (24.6±5.5 versus 28.9±5.2, F = 9.429, p = 0.003, respectively).

Conclusions/Significance

This finding suggests a role for the APOE gene in the diminished physiological complexity seen in elderly populations.

Introduction

Biologically, the physiological output of the human body emerges from interactions among a variety of factors, ranging from genes to organs to the environment [1]. These interactions, under healthy conditions, are essential for responses to environmental stress and are evident in both behavioral and physiological complexity, such as daily activities, heart rate, blood pressure, and brain electrical activities. In contrast, aging and illness are associated with degraded and/or decoupled regulatory networks and often result in the generation of less complex outputs [2], [3]. The loss of complexity is therefore, to a large extent, the hallmark of illness and the aging process [3], [4]. This reduced complexity can be quantified both behaviorally [4] and physiologically, such as through analysis of heart rate variability (HRV) [3]. However, despite a growing body of clinical and basic science research of applying complexity theory in aging and illness [2], [3], [4], [5], the relationship between the loss of such complexity and a genetic predisposition is still unclear.

The apolipoprotein-E (APOE) gene has been studied extensively in regard to its relationship to aging-associated medical illness, including cardiovascular disease [6], [7], [8], [9], geriatric cognitive decline [10], [11], and late-onset Alzheimer's disease [12]. The impact of the APOE polymorphism on the increased risk of a variety of medical illnesses might lead to a reduced life span and decreased adaptability of affected individuals to stress. These separate lines of evidence lead to our hypothesis that variants of the APOE gene (e.g., the ε4 allele) may potentially reduce physiological complexity in an affected individual, even before the onset of certain medical illness related to APOE variants. Therefore, in the present study, we applied a multiscale entropy (MSE) analysis to examine effects of the APOE genotypes on heart rate dynamics in a cohort of robust elderly adults.

Results

Descriptive statistics are summarized in Table 1. Clinical characteristics were not different between the APOE ε4-negative and ε4-positive groups, except that the gender distribution was unbalanced between two groups (male, %: 97.7 vs. 80.0, p = 0.02, respectively). A comparison of representative interbeat interval time series and MSE analysis between an APOE ε4-negative and an APOE ε4-positive subject is shown in Figure 1. There were no significant differences in conventional HRV measures between two groups (Table 2). We also found no significant correlations between the MSE and conventional HRV indices. Significantly lower values of MSE were found in the ε4-positive group compared to ε4-negative group (24.6±5.5 vs. 28.9±5.2, F = 9.429, p = 0.003, respectively). No significant MSE by ANCOVA covarying for age or clinical parameters interaction effect was found. Figure 2 shows the comparison of the MSE analysis for the entire study cohort by the APOE ε4 genotype at different time scales. For scales ranging from 3 to 13 (equal to interbeat interval time series of 10 to 40 heartbeats), the sample entropy values were significantly lower (t-test, p<0.01) for the group of APOE ε4-positive, as compared to the group without the APOE ε4 allele.

thumbnail
Figure 1. A comparison of a representative interbeat interval time series and analysis of multiscale entropy (MSE) between an APOE ε4-negative subject (top panels) and an APOE ε4-positive subject (bottom panels).

Time series length is 30 minutes. The APOE ε4-negative subject showed multiscale organizations in fluctuations of interbeat intervals, whereas a relatively monotonic oscillation was seen in the interbeat interval time series obtained from an APOE ε4-positive subject. By considering the impact of scale on entropy calculations, the sample entropy values for the APOE ε4-negative subject is higher than that for the APOE ε4-positive subject for scales larger than two. Of note, the sum of MSE from scale factor 1 to 20 was 28.3 for the APOE ε4-negative subject and 17.3 for the APOE ε4-positive subject.

https://doi.org/10.1371/journal.pone.0007733.g001

thumbnail
Figure 2. Multiscale entropy analysis by APOE ε4 genotype.

Multiscale entropy was derived from two-hours of interbeat interval time series. Symbols represent mean values of entropy for each group and the bars represent the standard error. Parameters of sample entropy calculation are m = 2 and r = 0.15. The sample entropy values for subjects with APOE ε4 allele are significantly lower (p<0.01) on scales between 3 and 13, which are equal to oscillations at period around 10 to 40 heartbeats. p values were computed using Student's t-test at each scale factor.

https://doi.org/10.1371/journal.pone.0007733.g002

Discussion

Consistent with our hypothesis, the key finding of this study is that reduced physiological complexity, as measured by multi-scale entropy analysis, is associated with the APOE ε4 allele in this robust, aged population. The concept of loss of physiological complexity in illness and during the aging process has been hypothesized by several literature sources [3], [4], [13]. Degeneration of the control mechanisms by illness and aging may lead to a breakdown of coupling between physiological components and thus result in the loss of complexity in heart rate dynamics [3]. Moreover, the lack of associations between MSE and other time-frequency HRV measures indicates that MSE contains new information (complexity) which was not quantified by conventional HRV indices. The findings of a relationship between the APOE ε4 allele and reduced physiological complexity at different time scales suggest that variants of the APOE gene may affect the integrity of the physiological system during the aging process. While the exact mechanism of how the APOE ε4 allele affects physiological functions is unclear, degeneration of overall brain functions associated with the APOE ε4 allele [14], [15], [16], [17], which further results in decoupling between physiological control systems, is a possible mechanism underlying the association between APOE ε4 allele and reduced physiological complexity.

The present study employed a nonlinear method adapted from complexity theory, multi-scale entropy, to detect changes in physiological complexity in an aged population. Cardiovascular signals are largely analyzed using traditional time and frequency domain measures. However, such measures fail to account for important properties related to multi-scale organization and nonequilibrium dynamics [3]. The complementary role of complexity analysis is, therefore, an important tool to quantify the nonlinear properties of physiological signals. Of note, reduced complexity (e.g., fractal properties) have been implicated in the risk of fatal cardiac arrhythmia, increased mortality, or poor prognosis in cardiovascular diseases [18], [19], [20], [21], [22]. Our findings of a relationship between reduced physiological complexity and the APOE ε4 allele is in line with the observation that APOE ε4 increases the risk of cardiovascular events in the long run [7], [8]. Limited studies have shown procedures/exercise (e.g., meditation or Tai-Chi exercise) that are able to increase vagal tone could have protective effect on heart functions [23], [24]. However, it's not clear whether these preventive means also alter the physiological complexity. Therefore, further research is warranted to examine if an appropriate treatment/prevention could compensate the adverse impact of APOE ε4 allele on physiologic functions.

There are limitations to this study. First, an evaluation of cardiovascular function was not done and, thus, we cannot exclude the possibility that subjects with this genetic finding also had occult cardiovascular disease. Second, the possibility of selection bias cannot be excluded due to the relatively small sample of subjects and biased gender distribution towards the male gender (majority of study subjects were veterans). Prior reports have shown that gender may modulate the association between APOE gene and related neuropathology [9], [25], [26], and therefore may potentially affect the result of HRV analysis. Gender effect should be factored in the future study. Third, as the study design was cross-sectional, we cannot directly evaluate the long-term impact of the APOE polymorphism on the physiological complexity and incidence of cardiovascular diseases. A prospective study with a larger population should be done to address this issue. Finally, interbeat interval time series obtained from this aged population also posed a challenge to HRV analysis as ectopic heartbeats or cardiac arrhythmia (e.g., atrial fibrillation) are more common in elderly populations. However, the subjects in the present study were generally healthy and had no severe cardiac arrhythmia, thus permitting the feasibility of applying HRV analysis to these aged individuals.

In conclusion, reduced physiological complexity, as measured by complexity analysis, was significantly associated with the presence of the APOE ε4 allele in healthy elderly subjects. This observation may provide implications for understanding the role of genetic predisposition in physiological aging. Further large-scale research is warranted to investigate the interactions between genes, physiological functioning, and the environment in the elderly.

Materials and Methods

Ethics Statement

All subjects gave written informed consent before commencement of the study. The protocol was approved by the Institutional Review Board of the Taipei Veterans General Hospital.

Study Sample

A total of 184 elderly Chinese-Han elderly volunteers were screened from a public veterans housing (N = 161) and a local elderly housing (N = 22) in the community. Of these subjects, 113 were successfully contacted for ambulatory electrocardiogram (ECG) monitoring. Each subject's history of medical disease, psychiatric illness, and medication use was evaluated carefully. Evaluation of the psychiatric history and of cognitive functioning was conducted by a psychiatrist. In addition, each subject underwent a basic physical examination and laboratory testing in order to gather data on clinical parameters. Subjects were screened and excluded if they had acute or major medical diseases (e.g., malignancy, heart failure, or infection), severe cardiac arrhythmia or frequent ectopic heartbeats, dementia (defined by clinical dementia rating scale >0.5), or a history of mental illness. Subjects were also excluded if they took medication with documented effects on the autonomic nervous system (e.g., beta-blockers). Of these 113 subjects, eleven were further excluded based on the above criteria. The final study sample consisted of 102 robust, non-demented elderly subjects with normal functions of daily activities (97 males and 5 females, aged 79.2±4.4 years, range 72–92 years).

Laboratory Methods and ECG Monitoring

APOE genotyping was determined using PCR-RFLP, according to the procedure reported previously [27]. The studies of APOE and cognitive functions as well as heart rate variability and cognitive functions has been reported elsewhere [28], [29]. Of the 102 subjects, there were four genotypes: ε2/ε2 (n = 1, 1.0%), ε2/ε3 (n = 14, 13.7%), ε3/ε3 (n = 72, 70.6%), and ε3/ε4 (n = 15, 14.7%). When the sample was stratified according to the presence of the ε4 allele, 15 (14.7%) were ε4 carriers compared with 87 (85.3%) non-ε4 carriers. The frequency of ε4 allele was comparable with prior studies worldwide based on the community sample (7.9%–16.5%) [30], [31], [32], [33], [34], [35]. These subjects then underwent two-hour electrocardiogram (ECG) monitoring using a Holter monitor (MyECG E3-80 Portable Recorder, Microstar Inc., Taipei, Taiwan). All ECG monitoring took place in the daytime and participants were asked to stay in the resting state and to avoid smoking and drinking alcoholic beverages before the experimental procedures.

The Holter device continuously recorded three channels of ECG signals at a sampling rate of 250 Hz. The ECG signals were then processed and analyzed by an open source of HRV algorithms [36]. Briefly, after detecting the QRS complex on ECG by locating the R apex, the interbeat interval data was automatically calculated as the time interval between two consecutive R peaks (R-R interval). All beat annotations were carefully checked to avoid erroneous detections or missed beats.

Analysis of Conventional Heart-Rate Variability

Conventional time and frequency domain HRV measures are employed. Time domain measures of HRV include the mean heart rate and standard deviation of the normal interbeat intervals (SDNN), the root mean square successive difference between adjacent normal interbeat intervals (RMSSD), and the percentage of adjacent intervals that varied by greater than 50 ms (pNN50) [37]. Spectral HRV measures [38] include high-frequency power (0.15–0.40 Hz), low-frequency power (0.04–0.15 Hz), and very-low-frequency power (0.003–0.04 Hz). Briefly, the RMSSD and pNN50 measure the short-term variation of interbeat intervals, which is mainly modulated by parasympathetic innervation [39]. Low-frequency power is suggested to be modulated by both sympathetic and parasympathetic activities, whereas high-frequency power is mainly modulated by parasympathetic activity [40], [41]. The low-frequency/high-frequency ratio was computed as a measure of the sympathovagal balance toward sympathetic activity [38], [42].

Analysis of Physiological Complexity

Physiological signals under healthy conditions typically exhibit multi-scale variability, long-range correlations, and non-linearity [43]. Traditional complexity measurements are based on the concept of entropy which quantifes the regularity (orderliness) of a time series. Entropy increases with the degree of disorder and is maximum for completely random systems. However, an increase in entropy may not always be associated with an increase in dynamical complexity. For instance, a randomized surrogate time series has higher entropy than the original time series, despite the process of generating the surrogate data destroys correlations and degrades the information content of the original signal. A biologically meaningful complexity measure has been proposed by measuring the entropy over multiple time scales inherent in physiologic signals, termed multiscale entropy (MSE) [44]. MSE was computed over the interbeat interval data using publicly available algorithms from the PhysioNet [36], [44]. The algorithm of MSE is as follows: Given a one-dimensional discrete time series, {x1,…, xi;…,xN}, we construct consecutive coarse-grained time series, {y(τ)}, determined by the scale factor, τ, according to the equation: , 1≤j≤N/τ. The length of each coarse-grained time series is equal to the length of the original time series divided by the scale factor, τ. For scale one, the time series is simply the original time series. We then calculate an entropy measure (sample entropy) for each coarse-grained time series and plot it as a function of the scale factorττ. The procedure and calculation of the MSE is summerized as following three steps: 1) construction of coarse-grained time series, 2) quantification of the sample entropy of each coarse-grained time series, and 3) summation of the sample entropy values over a range of scales. In the present study, sample entropy was calculated using a pattern length (m) of 2 and a similarity factor (r) of 0.15. The sum of sample entropy over all scale factors from 1 to 20 was computed for each subject and used to represent MSE in subsequent analyses. Of note, to reduce the non-stationarity beyond the maximum time scale detected by the MSE method (i.e., at scale 20, MSE can detect oscillation at the maximum of time period covering 61 heartbeats), interbeat interval time series was pre-detrended using the empirical mode decomposition method [45], [46].

Statistical Analysis

We performed allele and genotype frequency and Hardy-Weinberg equilibrium tests for each APOE genotype. Chi-square tests were used to compare categorical variables. Student's t-test was used to test for differences in demographic and clinical measures between APOE ε4 carriers and non-carriers. Analysis of covariance (ANCOVA) was employed to determine group differences for the HRV variables, controlling for age and clinical parameters effects in this study sample. Partial correlation analysis was applied, controlling for age and clinical measures, to determine the associations between conventional HRV indices and the MSE measure. A more rigorous p-value of less than 0.01 (two-tailed) for the nature of association study was required for statistical significance. Based on prior literatures of applying MSE in healthy elderly subjects [44], [47], we estimated the total sample size to be at least 94 by assuming power of 80%, 1% significance level, minimum expected difference of 5 and estimated standard deviation of 5.

Acknowledgments

The authors wish to thank Shan-Ing Chen, Cheng-Ju Wang, and Meng-Wei Wang for their excellent technical assistance and Dr. Chung-Kang Peng (Margret and H. A. Rey Institute for Nonlinear Dynamics in Medicine, Beth Israel Deaconess Medical Center/Harvard Medical School) for valuable discussions.

Author Contributions

Conceived and designed the experiments: SJT CJH ACY. Performed the experiments: DC. Analyzed the data: DC ACY. Contributed reagents/materials/analysis tools: SJT CJH ACY. Wrote the paper: DC ACY.

References

  1. 1. Park SK, O'Neill MS, Wright RO, Hu H, Vokonas PS, et al. (2006) HFE genotype, particulate air pollution, and heart rate variability: a gene-environment interaction. Circulation 114: 2798–2805.SK ParkMS O'NeillRO WrightH. HuPS Vokonas2006HFE genotype, particulate air pollution, and heart rate variability: a gene-environment interaction.Circulation11427982805
  2. 2. Goldberger AL, Amaral LA, Hausdorff JM, Ivanov P, Peng CK, et al. (2002) Fractal dynamics in physiology: alterations with disease and aging. Proc Natl Acad Sci U S A 99: Suppl 12466–2472.AL GoldbergerLA AmaralJM HausdorffP. IvanovCK Peng2002Fractal dynamics in physiology: alterations with disease and aging.Proc Natl Acad Sci U S A99Suppl 124662472
  3. 3. Goldberger AL, Peng CK, Lipsitz LA (2002) What is physiologic complexity and how does it change with aging and disease? Neurobiol Aging 23: 23–26.AL GoldbergerCK PengLA Lipsitz2002What is physiologic complexity and how does it change with aging and disease?Neurobiol Aging232326
  4. 4. Vaillancourt DE, Newell KM (2002) Changing complexity in human behavior and physiology through aging and disease. Neurobiol Aging 23: 1–11.DE VaillancourtKM Newell2002Changing complexity in human behavior and physiology through aging and disease.Neurobiol Aging23111
  5. 5. Kirkwood TB (2002) Changing complexity in aging: a metric not an hypothesis. Neurobiol Aging 23: 21–22.TB Kirkwood2002Changing complexity in aging: a metric not an hypothesis.Neurobiol Aging232122
  6. 6. Utermann G, Hardewig A, Zimmer F (1984) Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 65: 237–241.G. UtermannA. HardewigF. Zimmer1984Apolipoprotein E phenotypes in patients with myocardial infarction.Hum Genet65237241
  7. 7. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, et al. (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 272: 1666–1671.PW WilsonRH MyersMG LarsonJM OrdovasPA Wolf1994Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.JAMA27216661671
  8. 8. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, et al. (1995) Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91: 265–269.JH StengardKE ZerbaJ. PekkanenC. EhnholmA. Nissinen1995Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men.Circulation91265269
  9. 9. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, et al. (2009) APOE-related mortality: Effect of dementia, cardiovascular disease and gender. Neurobiol Aging 30: 1545–1551.L. RosvallD. RizzutoHX WangB. WinbladC. Graff2009APOE-related mortality: Effect of dementia, cardiovascular disease and gender.Neurobiol Aging3015451551
  10. 10. Christensen H, Batterham PJ, Mackinnon AJ, Jorm AF, Mack HA, et al. (2008) The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample. BMC Geriatr 8: 14.H. ChristensenPJ BatterhamAJ MackinnonAF JormHA Mack2008The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample.BMC Geriatr814
  11. 11. Reed T, Carmelli D, Swan GE, Breitner JC, Welsh KA, et al. (1994) Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol 51: 1189–1192.T. ReedD. CarmelliGE SwanJC BreitnerKA Welsh1994Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.Arch Neurol5111891192
  12. 12. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921–923.EH CorderAM SaundersWJ StrittmatterDE SchmechelPC Gaskell1993Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.Science261921923
  13. 13. Peng CK, Buldyrev SV, Hausdorff JM, Havlin S, Mietus JE, et al. (1994) Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system. Integr Physiol Behav Sci 29: 283–293.CK PengSV BuldyrevJM HausdorffS. HavlinJE Mietus1994Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system.Integr Physiol Behav Sci29283293
  14. 14. Jak AJ, Houston WS, Nagel BJ, Corey-Bloom J, Bondi MW (2007) Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord 23: 382–389.AJ JakWS HoustonBJ NagelJ. Corey-BloomMW Bondi2007Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults.Dement Geriatr Cogn Disord23382389
  15. 15. Isoniemi H, Kurki T, Tenovuo O, Kairisto V, Portin R (2006) Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology 67: 756–760.H. IsoniemiT. KurkiO. TenovuoV. KairistoR. Portin2006Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury.Neurology67756760
  16. 16. Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, et al. (2004) Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE-epsilon 4. Ann Neurol 55: 563–569.C. EnzingerS. RopeleS. SmithS. Strasser-FuchsB. Poltrum2004Accelerated evolution of brain atrophy and “black holes” in MS patients with APOE-epsilon 4.Ann Neurol55563569
  17. 17. Geroldi C, Pihlajamaki M, Laakso MP, DeCarli C, Beltramello A, et al. (1999) APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology 53: 1825–1832.C. GeroldiM. PihlajamakiMP LaaksoC. DeCarliA. Beltramello1999APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD.Neurology5318251832
  18. 18. Ho KK, Moody GB, Peng CK, Mietus JE, Larson MG, et al. (1997) Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics. Circulation 96: 842–848.KK HoGB MoodyCK PengJE MietusMG Larson1997Predicting survival in heart failure case and control subjects by use of fully automated methods for deriving nonlinear and conventional indices of heart rate dynamics.Circulation96842848
  19. 19. Chiu KM, Chan HL, Chu SH, Lin TY (2007) Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure. Auton Neurosci 132: 76–80.KM ChiuHL ChanSH ChuTY Lin2007Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failure.Auton Neurosci1327680
  20. 20. Makikallio TH, Koistinen J, Jordaens L, Tulppo MP, Wood N, et al. (1999) Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol 83: 880–884.TH MakikallioJ. KoistinenL. JordaensMP TulppoN. Wood1999Heart rate dynamics before spontaneous onset of ventricular fibrillation in patients with healed myocardial infarcts.Am J Cardiol83880884
  21. 21. Tapanainen JM, Thomsen PE, Kober L, Torp-Pedersen C, Makikallio TH, et al. (2002) Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol 90: 347–352.JM TapanainenPE ThomsenL. KoberC. Torp-PedersenTH Makikallio2002Fractal analysis of heart rate variability and mortality after an acute myocardial infarction.Am J Cardiol90347352
  22. 22. Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, et al. (1994) Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 90: 878–883.H. TsujiFJ Venditti JrES MandersJC EvansMG Larson1994Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study.Circulation90878883
  23. 23. Yeh GY, Wood MJ, Lorell BH, Stevenson LW, Eisenberg DM, et al. (2004) Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med 117: 541–548.GY YehMJ WoodBH LorellLW StevensonDM Eisenberg2004Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial.Am J Med117541548
  24. 24. Yeh GY, Mietus JE, Peng CK, Phillips RS, Davis RB, et al. (2008) Enhancement of sleep stability with Tai Chi exercise in chronic heart failure: preliminary findings using an ECG-based spectrogram method. Sleep Med 9: 527–536.GY YehJE MietusCK PengRS PhillipsRB Davis2008Enhancement of sleep stability with Tai Chi exercise in chronic heart failure: preliminary findings using an ECG-based spectrogram method.Sleep Med9527536
  25. 25. Ghebremedhin E, Schultz C, Thal DR, Rub U, Ohm TG, et al. (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56: 1696–1701.E. GhebremedhinC. SchultzDR ThalU. RubTG Ohm2001Gender and age modify the association between APOE and AD-related neuropathology.Neurology5616961701
  26. 26. Mortensen EL, Hogh P (2001) A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 57: 89–95.EL MortensenP. Hogh2001A gender difference in the association between APOE genotype and age-related cognitive decline.Neurology578995
  27. 27. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet 337: 1158–1159.PR WenhamWH PriceG. Blandell1991Apolipoprotein E genotyping by one-stage PCR.Lancet33711581159
  28. 28. Tsai SJ, Gau YT, Liu ME, Hsieh CH, Liou YJ, et al. (2008) Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Neurosci Lett 433: 158–162.SJ TsaiYT GauME LiuCH HsiehYJ Liou2008Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.Neurosci Lett433158162
  29. 29. Yang AC, Tsai SJ, Hong CJ, Yang CH, Hsieh CH, et al. (2008) Association between heart rate variability and cognitive function in elderly community-dwelling men without dementia: a preliminary report. J Am Geriatr Soc 56: 958–960.AC YangSJ TsaiCJ HongCH YangCH Hsieh2008Association between heart rate variability and cognitive function in elderly community-dwelling men without dementia: a preliminary report.J Am Geriatr Soc56958960
  30. 30. Liu HC, Hong CJ, Wang SJ, Fuh JL, Wang PN, et al. (1999) ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults. Neurology 53: 962–966.HC LiuCJ HongSJ WangJL FuhPN Wang1999ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults.Neurology53962966
  31. 31. Hong CJ, Liu TY, Liu HC, Wang SJ, Fuh JL, et al. (1996) Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population. Neurology 46: 1749–1751.CJ HongTY LiuHC LiuSJ WangJL Fuh1996Epsilon 4 allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population.Neurology4617491751
  32. 32. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, et al. (1991) The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49: 338–349.DM HallmanE. BoerwinkleN. SahaC. SandholzerHJ Menzel1991The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.Am J Hum Genet49338349
  33. 33. Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, et al. (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 46: 673–677.RH MyersEJ SchaeferPW WilsonR. D'AgostinoJM Ordovas1996Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.Neurology46673677
  34. 34. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, et al. (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55: 964–968.AJ SlooterM. CrutsS. KalmijnA. HofmanMM Breteler1998Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.Arch Neurol55964968
  35. 35. Kuusisto J, Koivisto K, Kervinen K, Mykkanen L, Helkala EL, et al. (1994) Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. Br Med J 309: 636–638.J. KuusistoK. KoivistoK. KervinenL. MykkanenEL Helkala1994Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.Br Med J309636638
  36. 36. Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, et al. (2000) PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 101: E215–220.AL GoldbergerLA AmaralL. GlassJM HausdorffPC Ivanov2000PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals.Circulation101E215220
  37. 37. Mietus JE, Peng CK, Henry I, Goldsmith RL, Goldberger AL (2002) The pNNx files: re-examining a widely used heart rate variability measure. Heart 88: 378–380.JE MietusCK PengI. HenryRL GoldsmithAL Goldberger2002The pNNx files: re-examining a widely used heart rate variability measure.Heart88378380
  38. 38. Task-Force (1996) Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043–1065.Task-Force1996Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use.Circulation9310431065
  39. 39. Goldberger JJ, Challapalli S, Tung R, Parker MA, Kadish AH (2001) Relationship of heart rate variability to parasympathetic effect. Circulation 103: 1977–1983.JJ GoldbergerS. ChallapalliR. TungMA ParkerAH Kadish2001Relationship of heart rate variability to parasympathetic effect.Circulation10319771983
  40. 40. Katona PG, Jih F (1975) Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J Appl Physiol 39: 801–805.PG KatonaF. Jih1975Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control.J Appl Physiol39801805
  41. 41. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, et al. (1985) Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 248: H151–153.B. PomeranzRJ MacaulayMA CaudillI. KutzD. Adam1985Assessment of autonomic function in humans by heart rate spectral analysis.Am J Physiol248H151153
  42. 42. Malliani A, Lombardi F, Pagani M (1994) Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms. Br Heart J 71: 1–2.A. MallianiF. LombardiM. Pagani1994Power spectrum analysis of heart rate variability: a tool to explore neural regulatory mechanisms.Br Heart J7112
  43. 43. Bar-Yam Y (1997) Dynamics of complex systems: Westview Press.Y. Bar-Yam1997Dynamics of complex systems: Westview Press.
  44. 44. Costa M, Goldberger AL, Peng CK (2002) Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett 89: 068102.M. CostaAL GoldbergerCK Peng2002Multiscale entropy analysis of complex physiologic time series.Phys Rev Lett89068102
  45. 45. Huang NE, Shen Z, Long SR, Wu MLC, Shih HH, et al. (1998) The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysis. Proc R Soc London, Ser A 454: 903–995.NE HuangZ. ShenSR LongMLC WuHH Shih1998The empirical mode decomposition and the Hilbert spectrum for nonlinear and non-stationary time series analysis.Proc R Soc London, Ser A454903995
  46. 46. Wu Z, Huang NE, Long SR, Peng CK (2007) On the trend, detrending, and variability of nonlinear and nonstationary time series. Proc Natl Acad Sci U S A 104: 14889–14894.Z. WuNE HuangSR LongCK Peng2007On the trend, detrending, and variability of nonlinear and nonstationary time series.Proc Natl Acad Sci U S A1041488914894
  47. 47. Costa M, Goldberger AL, Peng CK (2005) Multiscale entropy analysis of biological signals. Phys Rev E 71: 021906.M. CostaAL GoldbergerCK Peng2005Multiscale entropy analysis of biological signals.Phys Rev E71021906